Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phase II study of high dose weekly intravenous human lymphoblastoid interferon in renal cell carcinoma. A study of the National Cancer Institute of Canada Clinical Trials Group.

× No keyword cloud information.

5 in total

1. Interferon-alpha therapy of renal cancer.

Authors: J A Neidhart; M M Gagen; D Young; R Tuttle; T J Melink; A Ziccarrelli; D Kisner
Journal: Cancer Res Date: 1984-09 Impact factor: 12.701

2. Renal cell carcinoma: antitumor effects of leukocyte interferon.

Authors: J R Quesada; D A Swanson; A Trindade; J U Gutterman
Journal: Cancer Res Date: 1983-02 Impact factor: 12.701

3. Phase II study of interferon alpha in metastatic renal-cell carcinoma: a progress report.

Authors: J R Quesada; D A Swanson; J U Gutterman
Journal: J Clin Oncol Date: 1985-08 Impact factor: 44.544

4. Phase I study of weekly high-dose human lymphoblastoid interferon.

Authors: J M Connors; H K Silver
Journal: Cancer Treat Rep Date: 1984-09

5. A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial.

Authors: J M Kirkwood; J E Harris; R Vera; S Sandler; D S Fischer; J Khandekar; M S Ernstoff; L Gordon; R Lutes; P Bonomi
Journal: Cancer Res Date: 1985-02 Impact factor: 12.701

5 in total

2 in total

Review 1. Metastatic renal cell cancer--is the outlook really improving?

Authors: J Waxman; H Thomas
Journal: Postgrad Med J Date: 1990-06 Impact factor: 2.401

2. Phase II trial of LY 186641 in advanced renal cancer.

Authors: M Mahjoubi; J Kattan; M Bonnay; H Schmitt; J P Droz
Journal: Invest New Drugs Date: 1993-11 Impact factor: 3.850

2 in total